Business Wire

More than 2.5 billion records stolen or compromised in 2017

Jaa

Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, today released the latest findings of the Breach Level Index, revealing that 2.6 billion records were stolen, lost or exposed worldwide in 2017, an 88% increase from 2016. While data breach incidents decreased by 11%, 2017 was the first year publicly disclosed breaches surpassed more than two billion compromised data records since the Breach Level Index began tracking data breaches in 2013.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180410006200/en/

Chart of Number of Breach Incidents by Type and Source (Photo: Gemalto)

Chart of Number of Breach Incidents by Type and Source (Photo: Gemalto)

To learn more about the 2017 statistics and trends, register for the upcoming webinar “New Data Breach Findings: The Year of Internal Threats and Misplaced data”

Over the past five years, nearly 10 billion records have been lost, stolen or exposed, with an average of five million records compromised every day. Of the 1,765 data breach incidents in 2017, identity theft represented the leading type of data breach, accounting for 69% of all data breaches. Malicious outsiders remained the number one cybersecurity threat last year at 72% of all breach incidents. Companies in the healthcare, financial services and retail sectors were the primary targets for breaches last year. However, government and educational institutions were not immune to cyber risks in 2017, making up 22% of all breaches.

The Breach Level Index* serves as a global database that tracks and analyzes data breaches, the type of data compromised and how it was accessed, lost or stolen. Based on data breach reports collected in the Breach Level Index, the major 2017 highlights include:

  • Human error a major risk management and security issue: Accidental loss, consisting of improper disposal of records, misconfigured databases and other unintended security issues, caused 1.9 billion records to be exposed. A dramatic 580% increase in the number of compromised records from 2016.
  • Identity theft is still the number one type of data breach: Identity theft was 69% of all data breach incidents. Over 600 million records were impacted resulting in a 73% increase from 2016.
  • Internal threats are increasing: The number of malicious insider incidents decreased slightly. However, the amount of records stolen increased to 30 million, a 117% increase from 2016.
  • What a nuisance: The number of records breached in nuisance type attacks increased by 560% from 2016. The Breach Level Index defines a data breach as a nuisance when the compromised data includes basic information such as name, address and/or phone number. The larger ramification of this type of breach is often unknown, as hackers use this data to orchestrate other attacks.

"The manipulation of data or data integrity attacks pose an arguably more unknown threat for organizations to combat than simple data theft, as it can allow hackers to alter anything from sales numbers to intellectual property. By nature, data integrity breaches are often difficult to identify and in many cases, where this type of attack has occurred, we have yet to see the real impact,” said Jason Hart, Vice President and Chief Technology Officer for Data Protection at Gemalto. In the event that the confidentiality, or privacy, of the data is breached, an organization must have controls, such as encryption, key management and user access management, in place to ensure that integrity of the data isn’t tampered with and it can still be trusted. Regardless of any concerns around manipulation, these controls would protect the data in situ and render it useless the moment it's stolen.”

Data Breaches by Type
Identity theft was the leading type of data breach, accounting for 69% of all incidents constituting 26% of breached data in 2017. The second most prevalent type of breach was access to financial data (16%). The number of lost, stolen or compromised records increased the most for nuisance type of data breaches (560%) which constituted 61% of all compromised data. Account access and existential type breaches decreased both in incidents and records from 2016.

Data Breaches by Industry
In 2017, the industries that experienced the largest number of data breach incidents were healthcare (27%), financial services (12%), education (11%) and government (11%). In terms of the amount of records lost, stolen or compromised, the most targeted sectors were government (18%), financial services (9.1%) and technology (16%).

Data Breaches by Source
Malicious outsiders were the leading source of data breaches, accounting for 72% of breaches, however making up only 23% of all compromised data. While accidental loss was the cause of 18% of data breaches, it accounted for 76% of all compromised records, an increase of 580% from 2016. Malicious insider breaches were 9% of the total number of incidents, however this breach source experienced a dramatic increase (117%) in the number of compromised or stolen records from 2016.

“Companies can mitigate the risks surrounding a breach through a ‘security by design’ approach, building in security protocols and architecture at the beginning,” said Jason Hart, Vice President and Chief Technology Officer for Data Protection at Gemalto. “This will be especially important, considering in 2018 new government regulations like Europe’s General Data Protection Regulation (GDPR) and the Australian Privacy Act (APA) go into effect. These regulations require companies to adapt a new mindset towards security, protecting not only their sensitive data but the privacy of the customer data they store or manage.”

*The Breach Level Index is a global database that tracks data breaches and measures their severity based on multiple dimensions, including the number of records compromised, the type of data, the source of the breach, how the data was used, and whether or not the data was encrypted. By assigning a severity score to each breach, the Breach Level Index provides a comparative list of breaches, distinguishing data breaches that are a not serious versus those that are truly impactful (scores run 1-10).

Breach Level Index Resources:

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2017 annual revenues of €3 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

From secure software to biometrics and encryption, our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.

Our 15,000 employees operate out of 114 offices, 40 personalization and data centers, and 35 research and software development centers located in 47 countries.

For more information visit www.gemalto.com, or follow @gemalto on Twitter.

Contact information

Gemalto media contacts:
Tauri Cox
North America
+1 512 257 3916
tauri.cox@gemalto.com
or
Sophie Dombres
Europe Middle East & Africa
+33 4 42 36 57 38
sophie.dombres@gemalto.com
or
Jaslin Huang
Asia Pacific
+65 6317 3005
jaslin.huang@gemalto.com
or
Enriqueta Sedano
Latin America
+52 5521221422
enriqueta.sedano@gemalto.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 14:00Tiedote

Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines

Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 11:10Tiedote

Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest

Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 18:13Tiedote

Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,

Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 17:00Tiedote

Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With

Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 16:41Tiedote

Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel

Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 15:00Tiedote

Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme